Pertussis, commonly known as whooping cough, is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. While vaccination has dramatically reduced its burden in many countries, infants too young to complete their primary immunization series remain the most vulnerable group. In its severe form, infant pertussis can produce violent coughing paroxysms, an inspiratory whoop, cyanosis and profound respiratory distress. Complications such as pneumonia, pulmonary hypertension and encephalopathy contribute to the disease’s continued mortality in the youngest patients, and clinicians have long recognized that bacterial or viral co-infections can worsen outcomes substantially.

The infant in this case arrived with classic signs of whooping cough: paroxysmal coughing fits, crowing sounds during inspiration and increasing difficulty breathing. Laboratory evaluation painted a picture consistent with severe pertussis. Her white blood cell count was markedly elevated, a hallmark of the disease that reflects the toxin-driven lymphocytosis characteristic of Bordetella infection. A polymerase chain reaction test performed on sputum came back positive for Bordetella pertussis, confirming the diagnosis. Echocardiographic assessment revealed pulmonary hypertension, a dangerous elevation of pressure in the vessels supplying the lungs that is a recognized and feared complication of severe infant pertussis.

Based on these findings, the clinical team initiated treatment directed at the pertussis infection. Over the following days, two of the key indicators improved: the abnormally high leukocyte count came down, and the pulmonary artery pressure fell significantly. By conventional markers, the infant appeared to be responding to therapy. Yet her respiratory distress did not ease. This discordance, in which laboratory values normalize while the patient’s clinical condition deteriorates or fails to improve, is precisely the scenario in which clinicians should suspect that a second, undetected pathogen may be driving ongoing lung injury.

That suspicion led the team to deploy metagenomic next-generation sequencing, an unbiased diagnostic technique that differs fundamentally from targeted tests. Whereas PCR assays and cultures are designed to detect specific, suspected organisms, mNGS extracts all genetic material present in a clinical sample, in this case from the respiratory tract, and sequences it without any prior assumption about what might be found. Bioinformatic analysis then maps the resulting reads against comprehensive databases of bacterial, viral, fungal and parasitic genomes, allowing the technique to identify unexpected or fastidious pathogens directly from the sample. The approach has proven especially valuable in critically ill patients, in immunocompromised hosts and in infections where standard diagnostics repeatedly return negative results.

In this infant, mNGS detected genetic material from Pneumocystis jirovecii, an opportunistic fungus that causes Pneumocystis pneumonia, abbreviated PJP. The finding was significant for several reasons. Pneumocystis jirovecii is a yeast-like fungus that most commonly causes pneumonia in people with profoundly weakened immune systems, particularly those with untreated HIV, transplant recipients on immunosuppressive drugs, and children with severe primary immunodeficiencies. Its detection in an infant who was not known to be immunocompromised is rare, and co-infection with Pneumocystis in the setting of severe pertussis has been seldom reported in the medical literature. The authors note that PJP carries a higher mortality, making its timely recognition all the more critical.

The diagnosis, however, arrived late in the infant’s illness. Despite the eventual identification of the fungal co-pathogen, the delay meant that targeted therapy against Pneumocystis came after substantial lung damage had already accumulated. The girl died on the fifteenth day after admission. The authors draw a sobering conclusion from this outcome: Pneumocystis pneumonia can occur even in immunocompetent children with severe pertussis, and a delayed diagnosis may increase mortality. Their central recommendation is that mNGS should be performed when a patient with severe pertussis fails to respond to appropriate treatment, because the technique can provide an effective basis for identifying hidden co-infections that would otherwise remain undiagnosed until autopsy.

The case highlights a broader diagnostic dilemma in pediatric intensive care. Severe pertussis in young infants can produce a devastating pneumonia on its own, and the radiographic and clinical picture of Pneumocystis pneumonia overlaps considerably with other causes of diffuse lung injury, including viral pneumonias and the direct pulmonary effects of Bordetella itself. Furthermore, Pneumocystis cannot be reliably cultured in the laboratory, which means that conventional microbiological workups are structurally blind to it. Microscopic examination of induced sputum or bronchoalveolar lavage fluid with special stains has historically been the diagnostic mainstay, but these methods depend on adequate sampling, experienced microscopists and a clinician who thought to test for the organism in the first place. In an infant whose initial workup convincingly explained her illness with pertussis, the impetus to look for a second pathogen may only arise when the expected recovery stalls.

This is precisely the gap that mNGS is increasingly filling. Studies across adult and pediatric intensive care settings have shown that metagenomic sequencing can shorten the time to diagnosis of opportunistic infections, detect mixed infections involving multiple pathogens simultaneously and reveal organisms that were never suspected clinically. The technology is not without limitations: it is more expensive than targeted tests, results require careful interpretation because sequencing can detect colonizing organisms or environmental contaminants alongside true pathogens, and the quantity of genetic material recovered depends heavily on sample quality. Quantitative thresholds and clinical correlation remain essential to distinguish meaningful detections from background noise. Nevertheless, for critically ill children whose conditions defy explanation, the case-by-case evidence continues to mount that early deployment of unbiased sequencing can change management and, in some instances, alter outcomes.

The Hebei Children’s Hospital team also raises the question of why an apparently immunocompetent infant would develop Pneumocystis pneumonia at all. The report’s listing of related subjects includes severe combined immunodeficiency, and clinicians reading such a case would typically consider an underlying immune defect as a possible predisposing factor, since Pneumocystis infection in infancy can occasionally be the first manifestation of a primary immunodeficiency that had not previously come to attention. Severe pertussis itself may also perturb immune defenses in ways that create an opening for opportunistic organisms, though the precise mechanisms linking the two infections in this patient cannot be established from a single case. The authors’ work was approved by the ethics committee of Hebei Children’s Hospital, carried out in accordance with the Declaration of Helsinki, and published with written informed consent from the child’s legal guardian.

For the wider pediatric community, the report arrives at a moment of renewed attention to pertussis. Resurgence of the disease has been documented in multiple countries in recent years as vaccination rates fluctuate and immunity wanes, returning whooping cough to the differential diagnosis of infant respiratory illness with new urgency. The study, supported by the Medical Science Research Project of Hebei under grant number 20241732, was published open access on October 12, 2026, and its message is directed squarely at frontline clinicians: in an infant with severe pertussis whose respiratory distress persists despite improving leukocyte counts and falling pulmonary pressures, do not stop looking. A second pathogen may be hiding in the lungs, and metagenomic sequencing offers a way to find it before the window for effective treatment closes.

Subject of Research: Diagnosis of Pneumocystis jirovecii co-infection in severe infant pertussis using metagenomic next-generation sequencing

Article Title: Case report of a child with severe pertussis complicated by pneumocystis pneumonia diagnosed through mNGS

Article References: Guo, F., Wang, Y., Jia, Y., Wu, X., & Kang, L. (2026). Case report of a child with severe pertussis complicated by pneumocystis pneumonia diagnosed through mNGS. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07820-4

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07820-4

Keywords: pertussis, Bordetella pertussis, Pneumocystis jirovecii, pneumocystis pneumonia, metagenomic next-generation sequencing, mNGS, co-infection, infants, pulmonary hypertension, pediatric intensive care, case report, diagnostics

The research team, led by Hui Wu of the Jiangxi Provincial Center for Disease Control and Prevention together with colleagues from the Zhejiang Provincial Center for Disease Control and Prevention, set out to fill a conspicuous gap in the evidence base. While the global resurgence of pertussis has been documented extensively in infants and, more recently, in adolescents and young adults, population-based data on the economic consequences of infection among older adults in China were essentially nonexistent. Using multi-stage stratified sampling, the investigators recruited pertussis patients aged sixty or older from three prefecture-level cities in Zhejiang—Hangzhou, Jiaxing, and Jinhua—drawing on national surveillance records, hospital information systems, and face-to-face interviews conducted in 2025. Of those approached, 195 participants completed the study, a response rate of 81.3 percent that lends considerable weight to the findings.

The headline figure is striking: the aggregate economic burden across the cohort reached 1,366,260 RMB, with a mean total cost per case of 7,007 RMB. But averages in cost data can be misleading, and the distribution here was heavily skewed. The median total cost was just 1,819 RMB, with an interquartile range stretching from 653 to 9,234 RMB—a pattern indicating that most patients incurred modest expenses while a minority, chiefly those requiring hospital admission, absorbed enormous costs. This right-skewed distribution is precisely why the researchers turned to generalized linear models with a gamma distribution and log link, a statistical approach designed for non-negative, continuous cost data that would be distorted by ordinary linear regression.

Breaking the burden into its components reveals where the money actually goes. Direct costs—medical expenditures, medications, diagnostic tests, and travel to care—accounted for 75.9 percent of the total, with medical spending alone representing 69.3 percent of the overall burden. Indirect costs, primarily lost productivity and the value of unpaid caregiving time, contributed the remaining 24.1 percent. For a disease that many clinicians still associate with school-age children, these figures underscore that pertussis in older adults is a genuinely resource-intensive condition, one that consumes hospital beds, laboratory capacity, and family resources in equal measure.

The starkest contrast in the study emerged between outpatients and inpatients. Among patients treated without hospital admission, the median total economic burden was a comparatively manageable 811 RMB. Among those hospitalized, the median soared to 11,098 RMB—nearly fourteen times higher, a difference that was highly statistically significant. In the generalized linear model, inpatient status was by far the dominant driver of cost, multiplying the expected total burden by a factor of 11.93 compared with outpatient care. Fever independently increased costs by 32 percent, and each additional day between the onset of symptoms and diagnosis added roughly two percent to the expected total, reflecting how prolonged illness before confirmation compounds both medical and indirect expenses.

Perhaps the most consequential finding concerns hospitalization itself. The overall hospitalization rate among older adults with pertussis in the cohort was 40.5 percent—an extraordinarily high proportion for a vaccine-preventable bacterial infection, and one that signals substantial clinical severity in this age group. To identify who was most at risk, the team fitted a multivariable binary logistic regression model, adjusting for potential confounders and checking for multicollinearity using variance inflation factors. The results painted a clear portrait of vulnerability: rural residence nearly tripled the odds of hospitalization (odds ratio 3.08), male sex raised them nearly threefold (odds ratio 2.80), and each additional year of age increased the odds by 15 percent, a cumulative effect that grows rapidly across the later decades of life.

Clinical presentation mattered as much as demographics. Patients presenting with fever were more than four times as likely to be hospitalized as those without it (odds ratio 4.11), while the presence of complications—conditions such as pneumonia that often accompany pertussis in frail older bodies—nearly tripled the odds (odds ratio 2.94). A prolonged interval between symptom onset and diagnosis also independently elevated hospitalization risk, with each additional day increasing the odds by four percent. Taken together, these determinants suggest a dangerous feedback loop: delayed recognition of pertussis in older adults allows the infection to progress, complications to develop, and the eventual illness to become severe enough to demand inpatient care, which in turn drives the economic burden to its highest levels.

The technical rigor of the study deserves attention in its own right. Cost data violate the assumptions of ordinary least squares regression because they cannot be negative and cluster near zero with a long right tail; the gamma distribution with a log link handles this structure naturally, modeling costs on a multiplicative scale so that coefficients can be interpreted as proportional changes in expected expenditure. The logistic regression for hospitalization followed standard epidemiological practice, and the multi-stage stratified sampling design across three cities with different economic and geographic profiles strengthens the generalizability of the findings within Zhejiang, though the authors and independent observers alike would caution that a single-province, cross-sectional design cannot capture temporal changes or prove causation for the associations identified.

Why is pertussis resurging among the elderly in the first place? The bacterium Bordetella pertussis causes a respiratory infection whose classic symptom—a prolonged, paroxysmal cough—can last for weeks and, in older adults, is easily mistaken for bronchitis, asthma, or other common conditions. Immunity from childhood vaccination wanes over decades, and in China, as in most countries, routine booster vaccination of older adults with tetanus-diphtheria-acellular pertussis (Tdap) vaccines is not standard practice. Waning immunity, improved PCR-based diagnostics that detect infections previously missed, and the cyclical nature of pertussis epidemics all likely contribute to the surge documented in Zhejiang. Older adults also face age-related declines in respiratory reserve, making even a nominally mild infection far more dangerous than it would be in a vaccinated adolescent.

The public health implications are concrete. The authors argue that enhanced diagnosis, strengthened surveillance, and improved clinical management represent the most promising near-term strategies to reduce hospitalizations and blunt the economic burden. Practically, that means training frontline clinicians to consider pertussis in the differential diagnosis of prolonged cough in patients over sixty, expanding access to timely laboratory confirmation, and evaluating whether targeted Tdap vaccination of older adults—already recommended in several high-income countries—would be cost-effective in the Chinese context. With a 40.5 percent hospitalization rate and a per-case cost that can exceed 11,000 RMB for admitted patients, the study makes a compelling economic case that prevention in this age group is not merely a clinical nicety but a fiscal imperative. As populations across China and much of the world continue to age, the silent resurgence of whooping cough among the elderly is a warning that vaccine-preventable diseases never truly disappear—they simply find new, and sometimes older, hosts.

Subject of Research: Economic burden and hospitalization determinants of pertussis among older adults in Zhejiang, China

Article Title: Economic burden of pertussis, its influencing factors, and hospitalization determinants among older adults (≥ 60 years) in Zhejiang, China: a cross-sectional study (2024–2025)

Article References: Wu, H., Zhou, Y., Zhu, Y., He, H., & Guo, S. (2026). Economic burden of pertussis, its influencing factors, and hospitalization determinants among older adults (≥ 60 years) in Zhejiang, China: a cross-sectional study (2024–2025). BMC Public Health. https://doi.org/10.1186/s12889-026-29610-4

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29610-4

Keywords: pertussis, whooping cough, older adults, economic burden, hospitalization, Zhejiang, China, public health, health economics, vaccination, Bordetella pertussis, cross-sectional study

The headline finding is a measure of just how busy the respiratory pathogen world is in this region. Of the 1,716 patients enrolled in the study, 957 — or 55.77 percent — tested positive for at least one pathogen. Viruses dominated the spectrum, accounting for a 40.44 percent detection rate, while bacterial pathogens were found in 28.03 percent of samples. Most infections were caused by a single organism, at 34.15 percent, but a striking 21.51 percent of patients carried mixed infections, meaning two or more pathogens were detected simultaneously. That co-infection rate underscores a growing recognition in respiratory medicine that the old model of one microbe, one disease is often an oversimplification, particularly in children and in patients whose symptoms are severe enough to bring them to a hospital.

Demographics turned out to matter enormously. Children bore the heaviest pathogen load by far, with a detection rate of 69.81 percent in the pediatric group — nearly double the 35.68 percent seen in adults aged 66 and older, who had the lowest rate of any age bracket. This pattern is consistent with immunological reality: young children encounter most respiratory viruses for the first time and have not yet built the antibody repertoires that older adults accumulate over decades of exposure. Sex, by contrast, made essentially no difference. Male and female detection rates were almost perfectly matched, at 55.78 and 55.75 percent respectively, a difference so small it carried no statistical significance.

Perhaps the most socially revealing result was the urban-rural divide. Patients from urban areas tested positive 62.10 percent of the time, while those from rural districts were positive in only 20.28 percent of cases — a gap so large that the chi-square statistic reached 132.522 with a P value below 0.005. The authors of the study note that detection rates differed significantly across regions, and while the retrospective design cannot fully disentangle the reasons, several plausible mechanisms suggest themselves. Urban patients may reach the sentinel hospital earlier and more often, giving laboratory tests a better chance to catch pathogens before the immune system clears them. Differences in healthcare access, testing frequency, and exposure patterns between city and countryside could all contribute to what is, on its face, one of the starkest disparities in the dataset.

Seasonality, as expected, proved to be a powerful organizing force. Influenza A virus, the perennial driver of winter epidemics, peaked in the winter months with a detection rate of 20.40 percent. Rhinovirus, the most common cause of the common cold, reached its highest detection in autumn at 15.63 percent. Every major pathogen in the study displayed a significant seasonal pattern, reinforcing the idea that the calendar is one of the most reliable predictors of which microbe a clinician is likely to encounter. For hospitals in Kaifeng and comparable cities, this kind of seasonally resolved baseline is more than an academic curiosity: it can guide when to stock particular diagnostics, when to anticipate surges in pediatric admissions, and when to prioritize vaccination campaigns against specific influenza strains.

The study’s second major aim was more ambitious — to test whether environmental conditions, specifically temperature, precipitation, and fine particulate matter known as PM2.5, correlate with the ebb and flow of individual pathogens. This question has long fascinated epidemiologists. Laboratory studies show that cold, dry air stabilizes influenza virions and dries out the mucosal defenses of the airway, while air pollution can damage the epithelial lining of the lungs and impair the clearance of inhaled microbes. If those mechanisms translate cleanly into population-level patterns, one would expect strong statistical associations between meteorological variables and pathogen detection rates.

At first glance, the raw correlations looked promising. Influenza B virus detection showed a moderate negative correlation trend with precipitation, with a Spearman rank coefficient of −0.591 and a P value below 0.05, suggesting the virus was less often detected in wetter periods. Bordetella pertussis, the bacterium responsible for whooping cough, showed a moderate positive correlation trend with PM2.5 concentration, with a coefficient of 0.597 and a P value below 0.05 — the kind of result that would seem to support the idea that polluted air and bacterial respiratory infection travel together.

But the researchers did something that separates careful science from headline-chasing: they corrected for multiple comparisons. Because the team tested fifteen pathogens against three environmental variables, the analysis generated forty-five separate statistical tests. Under those conditions, a handful of nominally significant results are expected by pure chance alone. Applying the Bonferroni correction — a stringent threshold that lowered the significance cutoff to 0.0011 — neither the influenza B–precipitation link nor the B. pertussis–PM2.5 link survived. In the end, thirteen of the fifteen pathogens examined showed no statistically significant correlation with temperature, precipitation, or PM2.5, and the two marginal associations were flagged by the authors themselves as likely chance findings given the number of comparisons performed.

This kind of statistical honesty is worth pausing on, because it stands in contrast to a large body of published work that reports weather–pathogen associations without adequately accounting for the multiplicity of tests. Spearman correlation, the method used here, is an exploratory tool: it measures whether two variables rise and fall together in rank order, but it cannot establish causation, control for confounders such as seasonal testing patterns or school holidays, or distinguish a genuine biological signal from coincidence. The Kaifeng team’s decision to present their marginal findings transparently, while explicitly cautioning against overinterpretation, sets a methodological example for local surveillance studies elsewhere.

The practical value of the study lies less in its null environmental results than in the epidemiological baseline it establishes. For a city in Central China — a region the authors note has been underrepresented in multi-pathogen surveillance literature — the data provide a reference point against which future outbreaks, vaccine effects, and shifts in pathogen dominance can be measured. The findings argue for prevention strategies that are targeted by population and season rather than by weather forecast: intensified pediatric diagnostics and vaccination, attention to the diagnostic gap suggested by low rural detection rates, and winter preparedness for influenza A. As respiratory pathogens continue to circulate in an era of post-pandemic surveillance, local studies like this one, grounded in routine hospital testing and disciplined statistics, are the quiet infrastructure on which effective public health responses are built.

Subject of Research: Associations between meteorological factors and the respiratory pathogen spectrum in Kaifeng, China

Article Title: Association between meteorological factors and the respiratory pathogen spectrum in Kaifeng, China from 2023 to 2025: a retrospective analysis

Article References: Li, H., Chen, L., Li, Q., Liang, S.-S., & Zhao, H.-Y. (2026). Association between meteorological factors and the respiratory pathogen spectrum in Kaifeng, China from 2023 to 2025: a retrospective analysis. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14522-w

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14522-w

Keywords: acute respiratory infection, respiratory pathogens, meteorological factors, PM2.5, influenza, rhinovirus, Bordetella pertussis, seasonality, epidemiology, PCR surveillance, Kaifeng, China